Gilead Sciences (GILD) Current Taxes (2009 - 2015)

Gilead Sciences (GILD) reported Current Taxes of $356.0 million for Q2 2015, up 265.87% on a YoY basis from $97.3 million in Q2 2014, and up 263.27% quarter-over-quarter from $98.0 million in Q1 2015.

Gilead Sciences (GILD) Current Taxes (2009 - 2015) Analysis & Trends

Gilead Sciences has reported Current Taxes for 7 years, with the latest figure at $356.0 million in Q2 2015.

  • For the quarter ending Q2 2015, Current Taxes rose 265.87% year-over-year to $356.0 million; the trailing twelve-month figure through Jun 2015 stood at $356.0 million (up 265.87% YoY), and the FY2014 full-year result was $105.0 million, up 854.55% from the prior year.
  • Current Taxes for Q2 2015 stood at $356.0 million, up from $98.0 million in the prior quarter.
  • The five-year high for Current Taxes was $356.0 million in Q2 2015, with the low at $2.5 million in Q1 2011.
  • Historically, Current Taxes has averaged $59.5 million across 5 years, with a median of $26.5 million in 2011.
  • The largest YoY upside for Current Taxes was 2079.54% in 2011 against a maximum downside of 93.62% in 2011.
  • Gilead Sciences' Current Taxes stood at $40.6 million in 2011, then tumbled by 66.97% to $13.4 million in 2012, then slipped by 17.93% to $11.0 million in 2013, then soared by 854.55% to $105.0 million in 2014, then jumped by 239.05% to $356.0 million in 2015.
  • The last three Current Taxes figures came in at $356.0 million (Q2 2015), $98.0 million (Q1 2015), and $105.0 million (Q4 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn -748.24 Mn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn -
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn 1.09 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn -
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn 3.95 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn -
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn 3.13 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn -
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 356.00 Mn
Mar 31, 2015 98.00 Mn
Dec 31, 2014 105.00 Mn
Sep 30, 2014 43.78 Mn
Jun 30, 2014 97.30 Mn
Mar 31, 2014 152.95 Mn
Dec 31, 2013 11.00 Mn
Sep 30, 2013 10.65 Mn
Jun 30, 2013 37.97 Mn
Mar 31, 2013 19.24 Mn
Dec 31, 2012 13.40 Mn
Sep 30, 2012 17.09 Mn
Jun 30, 2012 11.85 Mn
Mar 31, 2012 14.49 Mn
Dec 31, 2011 40.58 Mn
Sep 30, 2011 33.67 Mn
Jun 30, 2011 5.44 Mn
Mar 31, 2011 2.46 Mn
Dec 31, 2010 1.86 Mn
Sep 30, 2010 38.71 Mn